These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10971105

  • 1. Growth hormone therapy in achondroplasia.
    Seino Y, Yamanaka Y, Shinohara M, Ikegami S, Koike M, Miyazawa M, Inoue M, Moriwake T, Tanaka H.
    Horm Res; 2000; 53 Suppl 3():53-6. PubMed ID: 10971105
    [Abstract] [Full Text] [Related]

  • 2. Effect of growth hormone therapy in children with achondroplasia: growth pattern, hypothalamic-pituitary function, and genotype.
    Tanaka H, Kubo T, Yamate T, Ono T, Kanzaki S, Seino Y.
    Eur J Endocrinol; 1998 Mar; 138(3):275-80. PubMed ID: 9539301
    [Abstract] [Full Text] [Related]

  • 3. Molecular defects in achondroplasia and the effects of growth hormone treatment.
    Seino Y, Moriwake T, Tanaka H, Inoue M, Kanzaki S, Tanaka T, Matsuo N, Niimi H.
    Acta Paediatr Suppl; 1999 Feb; 88(428):118-20. PubMed ID: 10102070
    [Abstract] [Full Text] [Related]

  • 4. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L, Karachaliou F, Neou P, Papataxiarchou K, Pistevos G, Bartsocas CS.
    Am J Med Genet; 1997 Oct 03; 72(1):71-6. PubMed ID: 9295079
    [Abstract] [Full Text] [Related]

  • 5. The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia.
    Tanaka N, Katsumata N, Horikawa R, Tanaka T.
    Endocr J; 2003 Feb 03; 50(1):69-75. PubMed ID: 12733711
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone (GH) treatment in achondroplasia.
    Yamate T, Kanzaki S, Tanaka H, Kubo T, Moriwake T, Inoue M, Seino Y.
    J Pediatr Endocrinol; 1993 Feb 03; 6(1):45-52. PubMed ID: 8374688
    [Abstract] [Full Text] [Related]

  • 7. Molecular basis for the treatment of achondroplasia.
    Yamanaka Y, Ueda K, Seino Y, Tanaka H.
    Horm Res; 2003 Feb 03; 60 Suppl 3():60-4. PubMed ID: 14671399
    [Abstract] [Full Text] [Related]

  • 8. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
    Kawai N, Kanzaki S, Takano-Watou S, Tada C, Yamanaka Y, Miyata T, Oka M, Seino Y.
    J Clin Endocrinol Metab; 1999 Jan 03; 84(1):82-9. PubMed ID: 9920066
    [Abstract] [Full Text] [Related]

  • 9. Human growth hormone treatment in prepubertal children with achondroplasia.
    Weber G, Prinster C, Meneghel M, Russo F, Mora S, Puzzovio M, Del Maschio M, Chiumello G.
    Am J Med Genet; 1996 Feb 02; 61(4):396-400. PubMed ID: 8834055
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone therapy in achondroplasia.
    Nishi Y, Kajiyama M, Miyagawa S, Fujiwara M, Hamamoto K.
    Acta Endocrinol (Copenh); 1993 May 02; 128(5):394-6. PubMed ID: 8317186
    [Abstract] [Full Text] [Related]

  • 11. [Updated treatment of achondroplasia].
    Seino Y.
    Clin Calcium; 2009 Mar 02; 19(3):432-6. PubMed ID: 19252254
    [Abstract] [Full Text] [Related]

  • 12. [Mutations in the Fibroblast Growth Factor Receptor 3 gene (FGFR3) in Chilean patients with idiopathic short stature, hypochondroplasia and achondroplasia].
    Mancilla EE, Poggi H, Repetto G, García C, Foradori A, Cattani A.
    Rev Med Chil; 2003 Dec 02; 131(12):1405-10. PubMed ID: 15022403
    [Abstract] [Full Text] [Related]

  • 13. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct 02; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 14. Treatment of achondroplasia with growth hormone: six years of experience.
    Ramaswami U, Rumsby G, Spoudeas HA, Hindmarsh PC, Brook CG.
    Pediatr Res; 1999 Oct 02; 46(4):435-9. PubMed ID: 10509364
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of growth hormone therapy for patients with skeletal dysplasia.
    Kanazawa H, Tanaka H, Inoue M, Yamanaka Y, Namba N, Seino Y.
    J Bone Miner Metab; 2003 Oct 02; 21(5):307-10. PubMed ID: 12928832
    [Abstract] [Full Text] [Related]

  • 16. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2003 Aug 02; 88(8):3584-90. PubMed ID: 12915640
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.
    Koike M, Yamanaka Y, Inoue M, Tanaka H, Nishimura R, Seino Y.
    J Bone Miner Res; 2003 Nov 02; 18(11):2043-51. PubMed ID: 14606518
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1996 Nov 02; 81(11):3902-8. PubMed ID: 8923836
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trial.
    Hertel NT, Eklöf O, Ivarsson S, Aronson S, Westphal O, Sipilä I, Kaitila I, Bland J, Veimo D, Müller J, Mohnike K, Neumeyer L, Ritzen M, Hagenäs L.
    Acta Paediatr; 2005 Oct 02; 94(10):1402-10. PubMed ID: 16299871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.